Shots: Henlius reported that TGA has approved the filing of clinical trial for HLX04-O to treat wet-AMD The two part P-III global study is expected to be initiated in Australia […]readmore
Tags : Initiate
Shots: Following the positive P-I results, Medicago has decided to launch the Phase 2/3 clinical trial with GSK’s pandemic adjuvant The study will evaluate the immunogenicity and safety profile of […]readmore
Shots: Novartis has received the FDA’s feedback following their review of data from the STRONG study of AVXS-101 (IT) in older patients with SMA. The FDA has recognized the potential […]readmore
Shots: The P-I/II will assess the safety, reactogenicity, and immunogenicity of the COVID-19 adjuvanted recombinant protein-based vaccine in 440 healthy adults across 11 sites in the US The companies are […]readmore
Biotech
Clinical Trials
COVID-19
GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831
Shots: The first patient has been dosed last week in a P-II/III COMET-ICE study with VIR-7831 for the early treatment of COVID-19 in patients who are at high risk of […]readmore
Shots: BIOEQ will sponsor the P-III study which will assess the FYB203 vs Eylea in patients with neovascular age-related macular degeneration (nAMD) to evaluate its efficacy, safety and immunogenicity. Additionally, […]readmore
Shots: In H1’21, Celltrion plans to initiate P-III trial for CT-P41 and is expected to commercialize in Feb 2025 when Amgen’s patents for Prolia expire in the US Celltrion is […]readmore
Shots: AstraZeneca collaborates with the Mexican and Argentinean governments to initially produce 150M doses of the vaccine and eventually make at least 400M for distribution throughout the region The price […]readmore
Shots: The P-I study will evaluate the safety and immunogenicity of the vaccine as well as confirm dose selection in ~144 healthy subjects aged 18-55 and >55 yrs. As part […]readmore
Shots: Eli Lilly initiates P-III BLAZE-2 study assessing LY-CoV555 to prevent SARS-CoV-2 infection and COVID-19 in residents and staff at long-term care facilities in the US (skilled nursing facilities, commonly […]readmore